Insulet falls after lowering 2026 revenue growth forecast
BUZZ-Insulet falls after lowering 2026 revenue growth forecast ** Shares of medical device maker Insulet PODD.O fall 12.2% to $146.4 premarket
** Co lowers its 2026 revenue growth to be between 20% and 22%, compared to its prior view in the 21% to 23% range
** Reports Q2 adjusted profit per share of $1.66, above analysts' estimates of $1.45 - LSEG data
** Posts Q2 revenue of $801.7 million, above analysts' estimates of $787.2 million - LSEG data
** As of last close, stock down 41.3% YTD
(Reporting by Siddhi Mahatole)